Hrubá A, Skala J P, Matĕjcková S, Fales I, Vodvárková S, Starý J, Kavan P, Kobylka P
Ustav hematologie a krevní transfuze, Praha.
Cas Lek Cesk. 1997 Mar 12;136(5):151-3.
The authors describe the results of purification of bone marrow and peripheral progenitor cells (PBPC) for clinical transplantations. Vepeside was used to purify in 1990-1995 a total of 41 bone marrows of adults and children. Of these 23 were transplanted. Maphosphamide was used bone marrow purging in two patients; transplantation was performed in one case. By a combination of Vepeside with methylprednisolone haematopoietic cells of 24 patients were purged, transplantations were performed in 10. Three-day cultivation of haematopoietic cells in the presence of Desferal was used for purging cells of 22 patients with neuroblastoma; transplantations were performed in 10 patients. The authors give the values of nucleated cells, haematopoietic colonies of CFU-GM and CD34 positive cells obtained after purification calculated per kg body weight of the patient and the percentage yields.
作者描述了用于临床移植的骨髓和外周祖细胞(PBPC)的纯化结果。1990年至1995年期间,使用威猛(依托泊苷)纯化了41例成人和儿童的骨髓。其中23例进行了移植。两名患者使用马磷酰胺进行骨髓净化;1例进行了移植。通过将威猛与甲基强的松龙联合使用,对24例患者的造血细胞进行了净化,10例进行了移植。在去铁胺存在的情况下对造血细胞进行三天培养,用于净化22例神经母细胞瘤患者的细胞;10例患者进行了移植。作者给出了纯化后每千克患者体重获得的有核细胞、CFU-GM造血集落和CD34阳性细胞的值以及回收率百分比。